vs
Side-by-side financial comparison of J.M. Smucker Company (The) (SJM) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.4B vs $2.3B, roughly 1.0× J.M. Smucker Company (The)). Zoetis runs the higher net margin — 25.3% vs 10.4%, a 14.9% gap on every dollar of revenue. On growth, Zoetis posted the faster year-over-year revenue change (3.0% vs 2.6%). Zoetis produced more free cash flow last quarter ($732.0M vs $280.2M). Over the past eight quarters, Zoetis's revenue compounded faster (4.4% CAGR vs 2.2%).
The J.M. Smucker Company, also known as Smucker's, is an American manufacturer of food and beverage products. Headquartered in Orrville, Ohio, the company was founded in 1897 as a maker of apple butter. J.M. Smucker currently has three major business units: consumer foods, pet foods, and coffee. Its flagship brand, Smucker's, produces fruit preserves, peanut butter, syrups, frozen crustless sandwiches, and ice cream toppings.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
SJM vs ZTS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $2.4B |
| Net Profit | $241.3M | $603.0M |
| Gross Margin | 37.3% | 70.2% |
| Operating Margin | 18.0% | 31.9% |
| Net Margin | 10.4% | 25.3% |
| Revenue YoY | 2.6% | 3.0% |
| Net Profit YoY | 1084.9% | 3.8% |
| EPS (diluted) | $2.26 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.3B | $2.4B | ||
| Q3 25 | $2.1B | $2.4B | ||
| Q2 25 | $2.1B | $2.5B | ||
| Q1 25 | $2.2B | $2.2B | ||
| Q4 24 | $2.3B | $2.3B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.2B | $2.4B | ||
| Q1 24 | $2.2B | $2.2B |
| Q4 25 | $241.3M | $603.0M | ||
| Q3 25 | $-43.9M | $721.0M | ||
| Q2 25 | $-729.0M | $718.0M | ||
| Q1 25 | $-662.3M | $631.0M | ||
| Q4 24 | $-24.5M | $581.0M | ||
| Q3 24 | $185.0M | $682.0M | ||
| Q2 24 | $245.1M | $624.0M | ||
| Q1 24 | $120.4M | $599.0M |
| Q4 25 | 37.3% | 70.2% | ||
| Q3 25 | 22.5% | 71.5% | ||
| Q2 25 | 38.4% | 73.6% | ||
| Q1 25 | 40.2% | 72.0% | ||
| Q4 24 | 39.0% | 69.5% | ||
| Q3 24 | 37.5% | 70.6% | ||
| Q2 24 | 41.4% | 71.7% | ||
| Q1 24 | 36.9% | 70.6% |
| Q4 25 | 18.0% | 31.9% | ||
| Q3 25 | 2.2% | 37.0% | ||
| Q2 25 | -27.9% | 36.7% | ||
| Q1 25 | -27.2% | 36.5% | ||
| Q4 24 | 7.5% | 31.6% | ||
| Q3 24 | 16.4% | 36.6% | ||
| Q2 24 | 18.4% | 33.0% | ||
| Q1 24 | 13.3% | 34.1% |
| Q4 25 | 10.4% | 25.3% | ||
| Q3 25 | -2.1% | 30.0% | ||
| Q2 25 | -34.0% | 29.2% | ||
| Q1 25 | -30.3% | 28.4% | ||
| Q4 24 | -1.1% | 25.1% | ||
| Q3 24 | 8.7% | 28.6% | ||
| Q2 24 | 11.1% | 26.4% | ||
| Q1 24 | 5.4% | 27.4% |
| Q4 25 | $2.26 | $1.37 | ||
| Q3 25 | $-0.41 | $1.63 | ||
| Q2 25 | $-6.86 | $1.61 | ||
| Q1 25 | $-6.22 | $1.41 | ||
| Q4 24 | $-0.23 | $1.29 | ||
| Q3 24 | $1.74 | $1.50 | ||
| Q2 24 | $2.31 | $1.37 | ||
| Q1 24 | $1.13 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $7.0B | — |
| Stockholders' EquityBook value | $6.1B | $3.3B |
| Total Assets | $17.6B | $15.5B |
| Debt / EquityLower = less leverage | 1.16× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $2.0B |
| Q4 25 | $7.0B | — | ||
| Q3 25 | $7.0B | — | ||
| Q2 25 | $7.0B | — | ||
| Q1 25 | $7.4B | — | ||
| Q4 24 | $7.8B | — | ||
| Q3 24 | $7.8B | — | ||
| Q2 24 | $7.8B | — | ||
| Q1 24 | $8.1B | — |
| Q4 25 | $6.1B | $3.3B | ||
| Q3 25 | $5.9B | $5.4B | ||
| Q2 25 | $6.1B | $5.0B | ||
| Q1 25 | $6.9B | $4.7B | ||
| Q4 24 | $7.6B | $4.8B | ||
| Q3 24 | $7.8B | $5.2B | ||
| Q2 24 | $7.7B | $5.0B | ||
| Q1 24 | $7.6B | $5.1B |
| Q4 25 | $17.6B | $15.5B | ||
| Q3 25 | $17.7B | $15.2B | ||
| Q2 25 | $17.6B | $14.5B | ||
| Q1 25 | $18.4B | $14.1B | ||
| Q4 24 | $20.0B | $14.2B | ||
| Q3 24 | $20.3B | $14.4B | ||
| Q2 24 | $20.3B | $14.2B | ||
| Q1 24 | $20.2B | $14.3B |
| Q4 25 | 1.16× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 1.01× | — | ||
| Q1 24 | 1.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $346.5M | $893.0M |
| Free Cash FlowOCF − Capex | $280.2M | $732.0M |
| FCF MarginFCF / Revenue | 12.0% | 30.7% |
| Capex IntensityCapex / Revenue | 2.8% | 6.7% |
| Cash ConversionOCF / Net Profit | 1.44× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | $635.5M | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $346.5M | $893.0M | ||
| Q3 25 | $-10.6M | $938.0M | ||
| Q2 25 | $393.9M | $486.0M | ||
| Q1 25 | $239.4M | $587.0M | ||
| Q4 24 | $404.2M | $905.0M | ||
| Q3 24 | $172.9M | $951.0M | ||
| Q2 24 | $428.1M | $502.0M | ||
| Q1 24 | $406.5M | $595.0M |
| Q4 25 | $280.2M | $732.0M | ||
| Q3 25 | $-94.9M | $805.0M | ||
| Q2 25 | $298.9M | $308.0M | ||
| Q1 25 | $151.3M | $438.0M | ||
| Q4 24 | $317.2M | $689.0M | ||
| Q3 24 | $49.2M | $784.0M | ||
| Q2 24 | $297.5M | $370.0M | ||
| Q1 24 | $249.6M | $455.0M |
| Q4 25 | 12.0% | 30.7% | ||
| Q3 25 | -4.5% | 33.5% | ||
| Q2 25 | 13.9% | 12.5% | ||
| Q1 25 | 6.9% | 19.7% | ||
| Q4 24 | 14.0% | 29.7% | ||
| Q3 24 | 2.3% | 32.8% | ||
| Q2 24 | 13.5% | 15.7% | ||
| Q1 24 | 11.2% | 20.8% |
| Q4 25 | 2.8% | 6.7% | ||
| Q3 25 | 4.0% | 5.5% | ||
| Q2 25 | 4.4% | 7.2% | ||
| Q1 25 | 4.0% | 6.7% | ||
| Q4 24 | 3.8% | 9.3% | ||
| Q3 24 | 5.8% | 7.0% | ||
| Q2 24 | 5.9% | 5.6% | ||
| Q1 24 | 7.0% | 6.4% |
| Q4 25 | 1.44× | 1.48× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | 0.93× | 1.39× | ||
| Q2 24 | 1.75× | 0.80× | ||
| Q1 24 | 3.38× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SJM
| U.S.Retail Frozen Handheld And Spreads | $461.1M | 20% |
| U.S.Retail Pet Foods | $413.2M | 18% |
| Handheld Frozen Sandwiches | $262.9M | 11% |
| Sweet Baked Snacks | $256.1M | 11% |
| Pet Snacks | $232.0M | 10% |
| Cat Food | $197.2M | 8% |
| Peanut Butter | $187.1M | 8% |
| CA | $94.5M | 4% |
| Fruit Spreads | $92.2M | 4% |
| Other | $50.5M | 2% |
| Portion Control | $50.1M | 2% |
| All Other International | $33.2M | 1% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
